
Divarus 125mg Tablet ER
Marketer
Icarus Healthcare Pvt Ltd
Salt Composition
Divalproex (125mg)
Overview Divarus 125mg Tablet ER
Epileptic seizures and migraine prophylaxis are key indications for the extended-release Divarus 125mg tablet. It can also be employed in bipolar disorder management, sometimes in conjunction with other therapies. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer with or without food, consistently at the same time daily for maximum efficacy; therapeutic effects typically manifest within a couple of weeks. Consistent use, as prescribed, is crucial; missed doses or abrupt cessation can exacerbate the underlying condition and potentially trigger seizures. Gradual discontinuation under medical supervision is essential. Commonly reported side effects include headache, visual disturbances, nausea, vomiting, vertigo, fatigue, ataxia, easy bruising, and hypothermia; most are mild and transient. Persistent or bothersome effects warrant consultation with your physician. Report any skin rashes or redness immediately. Prolonged therapy may reduce bone density (osteoporosis), increasing fracture risk. Suicidal ideation is a rare but potential adverse event; report any mood changes promptly. Prior to initiating Divarus 125mg ER, disclose any pre-existing cardiovascular issues, hepatic or renal impairment, urinary dysfunction, depression, or history of suicidal thoughts. Drug interactions are possible; inform your physician of all concurrent medications to ensure safety and efficacy. Pregnancy necessitates discussion with your doctor before initiating or altering treatment. Alcohol consumption should be avoided to minimize side effects and seizure risk. Regular blood monitoring may be required to optimize dosage, both before and during treatment.
Uses of Divarus 125mg Tablet ER
Managing epileptic seizures and bipolar disorder; migraine prevention.
Major Benefits of Divarus 125mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Divarus 125mg Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Divarus 125mg Tablet ER:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Divarus 125mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 125mg extended-release Divarus tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended.
How Divarus 125mg Tablet ER works:
Epileptic seizures are managed by Divarus 125mg Extended-Release tablets, an anticonvulsant that reduces hyperactive neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Divarus 125mg extended-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Divarus 125mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Divarus 125mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Divarus 125mg tablets may impair driving ability due to potential adverse effects.
KidneySAFE IF PRESCRIBED
Extended-release Divarus 125mg tablets are considered safe for use by individuals with impaired renal function. No modification to the Divarus 125mg extended-release tablet dosage is necessary.
LiverUNSAFE
Extended-release Divarus 125mg tablets are likely to be detrimental for individuals with hepatic impairment and should be omitted. Seek medical advice.
What if you forget to take Divarus 125mg Tablet ER :
Should you forget a Divarus 125mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Divarus 125mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Antiepileptic drugs targeting sodium channels |
